← Back to Clinical Trials
Recruiting NCT06974552

NCT06974552 The Effect of Different Support Surface Applications

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06974552
Status Recruiting
Phase
Sponsor Acibadem University
Condition Pressure Incidence Prevention
Study Type INTERVENTIONAL
Enrollment 72 participants
Start Date 2025-05-08
Primary Completion 2026-05-30

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type INTERVENTIONAL
Interventions
microbead-filled support surfacesJel support surfaces

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 72 participants in total. It began in 2025-05-08 with a primary completion date of 2026-05-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study was designed as a randomized controlled experimental study to compare the effects of two support surfaces-gel pads (used in routine practice) and microbead-filled pads-placed under the shoulders in the steep Trendelenburg position during robotic surgery, on the development of pressure injuries and pain.

Eligibility Criteria

Inclusion Criteria: * Patients scheduled to undergo robotic surgery in the lower pelvic region in the steep Trendelenburg position * Patients aged 18 years and older Exclusion Criteria: * Patients with existing pressure injuries * Patients with communication barriers * Patients with skin anomalies that interfere with skin assessment * Patients requiring conversion to open surgery during the procedure * Patients whose position is changed during surgery

Contact & Investigator

Central Contact

Ukke Karabacak, Prof

✉ ukke.karabacak@acibadem.edu.tr

📞 0902165004160

Frequently Asked Questions

Who can join the NCT06974552 clinical trial?

This trial is open to participants of all sexes, studying Pressure Incidence Prevention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06974552 currently recruiting?

Yes, NCT06974552 is actively recruiting participants. Contact the research team at ukke.karabacak@acibadem.edu.tr for enrollment information.

Where is the NCT06974552 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT06974552 clinical trial?

NCT06974552 is sponsored by Acibadem University. The trial plans to enroll 72 participants.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology